|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Topiramate forprevention of olanzapine associated weight gain andmetabolic dysfunction in schizophrenia: a double-blind,placebo-controlled trial显示文摘 | Narula PK Rehan HS Unni KE | 2010 | Schizophr Res2010，118，13： | 1 |
| 2 | Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study 显示文摘 | Kakkar AK Rehan HS Urmi KE | 2009 | Eur Psychiatry2009，24，3： | 1 |
| 3 | Topiramate for pre- vention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia a double-blind, placebo-con- trolled trial显示文摘 | Narula PK Rehan HS Unni KE | 2010 | Schizophr Res2010，118，13： | 1 |
| 4 | A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model显示文摘 | Chopra D Rehan HS Mehra P | 2009 | Int J Oral Maxillofac Surg2009，38，4： | 1 |
| 5 | Efficacy and safety of a single daily dose of gentamicin in hospitalized Indian children:a quasi-randomized trial显示文摘 | Tiwari S Rehan HS Chandra J | 2009 | J Antimicrob Chemother2009，64，5： | 1 |
| 6 | Topiramate for preven-tion of olanzapine associated weight gain and metabolic dysfunc-tion in schizophrenia:a double-blind,placebo-controlled trial显示文摘 | Narula PK Rehan HS Unni KE | 2010 | Schizophr Res2010，118，13： | 1 |
| 7 | Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia:A double-blind,placebo-controlled trial显示文摘 | Preeta Kaur Narula HS Rehan KES Unni | 2010 | Schizophrenia Research2010，118，13： | 1 |
| 8 | A randomized, double- blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model 显示文摘 | Chopra D Rehan HS Mehra P | 2009 | Int J Oral Maxillofac Surg2009，38，4： | 1 |
| 9 | Changes in quality of life after surgical removal of impacted mandibular third molar teeth 显示文摘 | Deepti Chopra Rehan HS Mehra P | 2008 | J Maxillofac Oral Surg2008，8，3： | 1 |
| 10 | Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial显示文摘 | Narula PK Rehan HS Unni KE | 2010 | Schizophr Res2010，118，13： | 1 |
| 11 | Changes in quality of life after sur- gical removal of impacted mandibular third molar teeth 显示文摘 | Chopra D Rehan HS Mehra P | 2008 | J Oral Maxillofac Surg2008，8，3： | 1 |
| 12 | Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia a double blind, placebo-con- trolled trial 显示文摘 | Narula PK Rehan HS Unni KE | 2010 | Schizophr Res2010，118，13： | 1 |
| 13 | Changes in quality of life after surgical removal of impacted mandibular third molar teeth显示文摘 | Deepti C Rehan HS Mehra P | | 0，，03： | 1 |
| 14 | Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double blind, placebo con trolled trial 显示文摘 | Narula PK Rehan HS Unni KE el al | 2010 | Schizophr Res2010，118，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员